Amol Kulkarni to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Amol Kulkarni has written about Dose-Response Relationship, Drug.
Connection Strength
0.080
-
Zhang C, Sajith AM, Xu X, Jiang J, Phillip Bowen J, Kulkarni A, Hao J. Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation. Bioorg Med Chem. 2022 03 15; 58:116645.
Score: 0.037
-
Kumari N, Kulkarni AA, Lin X, McLean C, Ammosova T, Ivanov A, Hipolito M, Nekhai S, Nwulia E. Inhibition of HIV-1 by curcumin A, a novel curcumin analog. Drug Des Devel Ther. 2015; 9:5051-60.
Score: 0.024
-
Hurley LL, Akinfiresoye L, Nwulia E, Kamiya A, Kulkarni AA, Tizabi Y. Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF. Behav Brain Res. 2013 Feb 15; 239:27-30.
Score: 0.019